SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-18-003244
Filing Date
2018-09-27
Accepted
2018-09-27 17:36:14
Documents
2
Period of Report
2018-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 4854
2 yelensky.htm EX-24 10883
  Complete submission text file 0001567619-18-003244.txt   17126
Mailing Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Issuer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GRITSTONE ONCOLOGY, INC. 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address
Yelensky Roman (Reporting) CIK: 0001754293 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38663 | Film No.: 181091956